Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Loading...Loading...Loading...Loading...

Trending Tickers

DJT logo
Top trending tickerDJT
$8.85
1.96%
#1
Escalating U.S.-Iran tensions and uncertainty over negotiations are driving attention to DJT, with traders focused on potential military action, Strait of Hormuz disruptions, higher energy costs, and broader inflation and economic risk. Supporters view Trumps foreign-policy moves as strengthening U.S. security, while critics argue the conflict, rising fuel costs, and media restrictions are damaging the economy and his political standing.
NEAR logo
NEAR
$4.14
17.19%
#2
Traders are linking NEARs sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, with privacy-focused leveraged trading emerging as the immediate catalyst. The move has strengthened bullish discussion around NEARs AI, agent and cross-chain infrastructure, though some traders view the surge as momentum- or liquidity-driven and warn of a pullback.
UEC logo
UEC
$9.81
3.06%
#3
Uranium Energy is drawing attention after its fiscal Q3 update showed production ramping but no uranium sales, prompting concerns about near-term revenue, operating costs and valuation. Traders remain divided, with bears focused on execution and dilution risk while bulls point to the companys cash-rich, debt-free balance sheet, unhedged inventory and longer-term U.S. nuclear-fuel demand.
CRML logo
CRML
$6.73
2.04%
#4
A reported U.S.-Denmark-Greenland security agreement has put CRMLs Tanbreez rare-earth project at the center of renewed critical-minerals speculation, with traders viewing restrictions on Chinese and Russian investment as a strategic tailwind. Bullish participants expect sector momentum and possible short covering, while skeptics note the agreement is not a direct mining, funding, or permitting commitment and does not change the projects development timeline.
MP logo
MP
$47.26
4.29%
#5
ChinaU.S. tensions over rare-earth exports and negotiations are driving attention to MP, alongside continued discussion of its government-backed domestic mine-to-magnet expansion and planned GM magnet deliveries. Traders are divided between a bullish view that supply-chain restrictions and U.S. support strengthen MPs strategic position and concerns that a China deal or broader weakness could pressure the stock in the near term.
NASA logo
NASA
$23.94
0.87%
#6
SpaceXs public-market debut, subsequent selloff, and expected lockup-related selling have become the dominant focus, with traders saying NASAs sizable SpaceX exposure is weighing on the broader space ETF. The community is split between frustration over underperformance and concerns about fund management versus long-term investors averaging down on the space-sector theme.
STRK logo
STRK
$0.0487
14.32%
#7
Starknets privacy and BitcoinFi pushparticularly the rollout of strkBTC and STRK20 for shielded Bitcoin and ERC-20 transactionsis driving attention, alongside its post-quantum STARK technology. Traders are bullish on the differentiated infrastructure and growing ecosystem activity, while others remain cautious about token-unlock-related selling pressure and weak price structure.
CLF logo
CLF
$12.54
1.72%
#8
Speculation around a potential POSCO strategic partnership remains the main focus, with traders debating whether a deal will be finalized or abandoned and how it could affect Cleveland-Cliffs valuation and debt position. The discussion is reinforced by improving hot-rolled steel prices, expectations for stronger upcoming results, and elevated short interest, prompting both short-squeeze optimism and skepticism over leverage and profitability.
KURA logo
KURA
$11.73
0.09%
#9
Repeated open-market purchases by CEO Troy Wilson, including another 100,000-share buy, are driving attention and being viewed by traders as a confidence signal in Kuras oncology pipeline and KOMZIFTI launch. The community is broadly bullish and watching for short covering, though some traders remain cautious about valuation, commercialization execution, and biotech risk.
DRTS logo
DRTS
$15.60
0.71%
#10
Clinical pipeline milestones are driving attention, particularly completed enrollment in the IMPACT pancreatic cancer study and upcoming glioblastoma data and a potential FDA IDE for Alpha DaRT combined with Keytruda. Traders are broadly bullish on the early clinical results and stacked catalyst calendar, though some note the stock remains range-bound near resistance and that several developments are still anticipated rather than confirmed.

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.